1 Min Read
Jan 22 (Reuters) - Htg Molecular Diagnostics Inc:
* STONEPINE CAPITAL MANAGEMENT LLC REPORTS A 5.6 PERCENT PASSIVE STAKE IN HTG MOLECULAR DIAGNOSTICS INC AS OF JANUARY 19 - SEC FILING Source text - bit.ly/2G2Dlxg Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.